Abstract
Cardiogenic shock (CS) remains the leading cause of ST-elevation myocardial infarction (STEMI)-related mortality. Over the years, despite impressive mortality reduction during STEMI, CS mortality rates remained high and constant. Contemporary studies (e.g., SHOCK, SHOCK IABP-II and SHOCK-MVD) showed
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
